p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma

Histopathology

Volumn 33, Issue 4, 1998, Pages 311-317

  Leung, S Y ^a,b   Chau, K Y ^a   Yuen, S T ^a   Chu, K M ^a   Branicki, F J ^a   Chung, L P ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Carcinoma; Epstein Barr virus; Immunohistochemistry; P53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CARCINOMA; EPSTEIN BARR VIRUS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS CARCINOGENESIS;

CARCINOMA; FEMALE; HEAD AND NECK NEOPLASMS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0031768535     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Niedobitek G, Agathanggelou A, Barber P, Smallman LA, Jones EL, Young LS. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J. Pathol. 1993: 170; 457-461.
2. Sheu LF, Chen A, Tseng HH, Leu FJ, Lin JK, Meng CL. Expression of p53 protein in nasopharyngeal carcinoma. J. Pathol. 1994: 172; 294-296.
3. Sheu LF, Chen A, Tseng HH et al. Assessment of p53 expression in nasopharyngeal carcinoma. Hum. Pathol. 1995: 26; 380-386.
4. Kanavaros P, Kouvidou C, Dai Y. MDM-2 protein expression in nasopharyngeal carcinomas - comparative study with p53 expression. J. Clin. Pathol. Clin. Mol. Pathol. 1995: 48; M 322-M 325.
5. Nasrin N, Taiba K, Hannan N, Hannan M, al Sedairy S. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients. Cancer Lett. 1994: 82; 189-198.
6. Effert P, McCoy R, Abdel Hamid M et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol. 1992: 66; 3768-3775.
7. Lo KW, Mok CH, Huang DP et al. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res. 1992: 12; 1957-1963.
8. Sun Y, Hegamyer G, Cheng YJ et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 1992: 89; 6516-6520.
9. Spruck CH, 3rd Tsai YC, Huang DP et al. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 1992: 52; 4787-4790.
10. Gabbert HE, Muller W, Schneiders A, Meier S, Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995: 76; 720-726.
11. Hurlimann J, Saraga EP. Expression of p53 protein in gastric carcinomas. Association with histologic type and prognosis. Am. J. Surg. Pathol. 1994: 18; 1247-1253.
12. Ranzani GN, Luinetti O, Padovan LS et al. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol. Biomarkers Prev. 1995: 4; 223-231.
13. Strickler JG, Zheng J, Shu Q, Burgart LJ, Alberts SR, Shibata D. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res. 1994: 54; 4750-4755.
14. Renault B, van den Broek M, Fodde R et al. Base transitions are the most frequent genetic changes at P53 in gastric cancer. Cancer Res. 1993: 53; 2614-2617.
15. Maesawa C, Tamura G, Suzuki Y et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenomacarcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J. Pathol. 1995: 176; 249-258.
16. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am. J. Surg. Pathol. 1994: 18; 1158-1163.
17. Leung SY, Yuen ST, Chung LP, Kwong WK, Wong MP, Chan SY. Epstein-Barr virus is present in a wide histological spectrum of sinonasal carcinomas. Am. J. Surg. Pathol. 1995: 19; 994-1001.
18. Leung SY, Chung LP, Yuen ST, Ho CM, Wong MP, Chan SY. Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein-Barr virus. J. Clin. Pathol. 1995: 48; 1022-1027.
19. Leung SY, Chung LP, Ho CM, Yuen ST, Wong MP, Kwong WK. An Epstein-Barr virus positive undifferentiated carcinoma in the lacrimal sac. Histopathology 1996: 28; 71-75.
20. McKee PH, Hobbs C, Hall PA. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993: 23; 377-379.
21. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J. Pathol. 1994: 172; 1-4.
22. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 1994: 172; 5-12.
23. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum. Pathol. 1996: 27; 20-27.
24. Ojima H, Fukuda T, Makajima T, Nagamachi Y. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J. Cancer Res. 1997: 88; 262-266.
25. Nagao T, Ishida Y, Sugano I et al. Epstein-Barr virus-associated undifferentiated carcinoma with lymphoid stroma of the salivary gland in Japanese patients. Comparison with benign lymphoepithelial lesion. Cancer 1996: 78; 695-703.
26. Szekely L, Selivanova G, Magnusson KP, Klein G, Wiman KG. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 1993: 90; 5455-5459.
27. Zhang Q, Gutsch D, Kenney S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell Biol. 1994: 14; 1929-1938.
28. Okan I, Wang Y, Chen F et al. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 1995: 11; 1027-1031.
29. Fries KL, Miller WE, Raab Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 1996: 70; 8653-8659.